MIRA Pharmaceuticals, Inc. (MIRA) News
Track canonical SquawkNews coverage tagged to MIRA, MIRA Pharmaceuticals, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 4 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
MIRA - MIRA Reports Positive 7-Day Dog Study Results for SKNY-1
MIRA - MIRA Reports Positive 7-Day Dog Study Results for SKNY-1
EQUITY | Aug 06, 2026, 12:00 PM UTC
M
MIRA progresses MIRA-55 and SKNY-1
MIRA advances two pharmaceutical products
EQUITY | Jul 30, 2026, 12:01 PM UTC
L
Mira Pharmaceuticals Says SKNY-1 in Obesity, Addiction Shows 'Favorable' Bioavailability in Preclinical Studies
() -- Mira Pharmaceuticals (MIRA) said Monday that preclinical studies evaluating the oral formulation of SKNY-1 for obesity and addiction-related disorders showed "favorable" bioavailability along with reproducible syst
EQUITY | Jul 06, 2026, 01:44 PM UTC
M
MIRA Reports Preclinical Data
MIRA Pharmaceuticals reports new preclinical data demonstrating Mira-55's differentiated mechanism of action and anxiolytic activity relative to THC
EARNINGS | Jun 25, 2026, 12:15 PM UTC